NovoPath, Inc.

Princeton,  NJ 
United States
http://www.novopath.com
  • Booth: 1644

Booth Profile

NovoPath, Inc. is a leading U.S.-based Lab Information Systems (LIS) company with over 25 years of experience serving the Anatomic and Clinical Pathology, Molecular and Genetic Testing, and Clinical Trials markets. NovoPath's clients include national and regional reference labs, university and teaching hospitals, regional and community hospitals, and specialty labs.


 Press Releases

  • NEWS PROVIDED BY

    NovoPath, Inc.

    January 4, 2018, 08:40 ET

    PRINCETON, N.J., January 4, 2018 /PRNewswire/ -- NovoPath, Inc. announces the integration of the NovoPathTM Anatomic Pathology Software Platform with Philips IntelliSite Pathology Solution and Wholeslide Imaging System. This announcement follows a thorough process of development and testing to integrate anatomic pathology (AP) workflows between Philips IntelliSite Image Management System and NovoPath’s Anatomic Pathology LIS software at a major client that employs both technologies.

    “Using the NovoPath AP LIS together with Philips’ digital imaging solutions will provide lab managers and pathologists a top-of-the-line, integrated viewing and resulting solution of digitized slides,” said Rick Callahan, Vice President of Sales and Marketing for NovoPath. “The integration seamlessly and elegantly combines the workflow of both systems to provide an efficient tool for viewing and capturing relevant information, improving turnaround time in the lab, and providing a more pleasant user experience.”

    “The full efficiency gains of a digital workflow in pathology will only be obtained when information technology systems from vendors work together seamlessly to support pathologists in their daily tasks,” said Jasper Peeters, Head of Product Management at Philips Digital Pathology Solutions. “Philips IntelliSite Pathology Solution’s flexible system design allows for bi-directional integration with leading LIS vendors, such as NovoPath, to provide our mutual customers with actionable information where and when they need it most.”

    NovoPath continues to partner with other innovators in the healthcare sector to allow labs the flexibility to choose the best vendors for their needs and to succeed in the ever-changing laboratory environment. Labs that work with or would like to work with Philips can now confidently do so with NovoPath as their LIS.

    To experience the benefits of NovoPath firsthand, visit www.NovoPath.com and request a complimentary demonstration.

    About NovoPath

    NovoPath, Inc. is a leading U.S.-based Lab Information Systems (LIS) company with over 24 years of experience in serving the Anatomic, Clinical and Molecular Pathology, Genetic Testing and Clinical Trials marketplaces.  NovoPath's clients range from national and regional reference labs to University and Teaching Hospitals, Regional and Community Hospitals and Specialty Labs.  NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Diagnostic Laboratory sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes.

  • PRINCETON, N.J., April 30, 2018 /PRNewswire/ -- NovoPath, Inc. announces that the University of Texas Health Science Center at Houston (UTHealth) has selected the NovoPath™ Anatomic Pathology Software
    Platform as its LIS for the Department of Pathology and Laboratory Medicine. UTHealth, the most comprehensive academic health center in the UT System and the U.S. Gulf Coast region, is Houston’s Health University and Texas’ resource for health care education and excellence in patient care.
    “We are pleased that UTHealth chose NovoPath for its AP platform as it continues to grow and expand its services” said Rick Callahan, Vice President of Sales and Marketing for NovoPath. “The UTHealth team did a very thorough evaluation of its needs and followed a rigorous vendor selection process. We are proud that UTHealth selected NovoPath.”

    “Pathology programs are data intensive and a large volume of records must be managed securely. With the new generation of software platforms such as NovoPath, health care providers can customize this information to meet their particular needs and support future growth,” said Robert Hunter, M.D., Ph.D., Chair of Pathology and Laboratory Medicine and the holder of the Distinguished Chair in Molecular Pathology at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). NovoPath continues to partner with lab industry leaders in the healthcare sector to succeed in the everchanging laboratory  environment.

    To experience the benefits of NovoPath firsthand, visit www.NovoPath.com and request a
    complimentary demonstration.
    About NovoPath
    NovoPath, Inc. is a leading U.S.-based Lab Information Systems (LIS) company with over 24 years of experience in serving the Anatomic, Clinical and Molecular Pathology, Genetic Testing and Clinical Trials marketplaces. NovoPath's clients range from national and regional reference labs to University and Teaching Hospitals, Regional and Community Hospitals and Specialty Labs. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Diagnostic Laboratory sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes.

  • PRINCETON, N.J., April 10, 2018 /PRNewswire/ -- NovoPath, Inc., makers of the NovoPath™ Laboratory Information System Software, will sponsor an educational session on how laboratories can use LEAN and Six Sigma principles at the 23rd annual Executive War College (EWC) Conference on Laboratory and Pathology Management which will be held between April 30 and May 2, 2018 in New Orleans.  During the Tuesday May 1, 7:00 AM NovoPath Benefactor Sponsored Session, Leo Serrano (FACHE, DLM (ASCP) and LEAN Six Sigma Black Belt) will be speaking on “Using Your LIS to Design and Improve your LEAN Laboratory”. Leo has over 50 years of laboratory management experience with an extensive background in Outreach Laboratory Services, Quality Management and Process Improvement. He also directed the first U.S. hospital laboratory to achieve ISO-15189 accreditation, which re-accredited for a second cycle.
    “With challenges such as reimbursement reductions and increased regulations, applying Lean principles when designing or redesigning workflow in the lab, could yield substantial and measurable results in reducing bottle necks, identifying waste, reducing the probability of patient errors and improving profitability in general” said Rick Callahan, Vice President of Sales and Marketing for NovoPath.
    “Healthcare and laboratory medicine are changing at an accelerating rate,” stated Robert L. Michel, Founder and Organizer of the Executive War College. “This is why innovative laboratories are tapping the resources of companies such as NovoPath to learn about the best practices in lab management and operations used by their most progressive lab clients—best practices that they can adopt and implement in their own laboratory to stay clinically relevant and financially robust.”
  • NovoPath’s AP LIS Receives Frost & Sullivan Technology Leadership Award for its Advanced Features that Transform AP Laboratory Workflow

    June 05, 2018 at 8:00 AM


    NovoPath’s AP LIS Receives Frost & Sullivan Technology Leadership Award for its Advanced Features
    that Transform AP Laboratory Workflow

    NovoPath's modules offer robust functionality using the latest industry techniques to boost
    productivity and enable material cost savings for labs aiming for a higher grade of operations

    SANTA CLARA, Calif. — June 5, 2018 — Based on its recent analysis of the North American market for
    anatomic pathology laboratory information systems (AP LIS), Frost & Sullivan recognizes NovoPath,
    Inc. with the 2018 North American Enabling Technology Leadership Award. Over the last two decades,
    NovoPath’s LIS software for AP, simply called NovoPath™, has consistently garnered high ratings
    from clients for its continual improvement and functional expansion, as well as its ease of use.
    NovoPath™ offers an array of modules inspired by client needs and a strong understanding of
    technology and market trends. These modules increase productivity and efficiency by streamlining
    workflow, promoting superior diagnostic outcomes, and providing lab managers a real-time view into
    their operations.

    NovoPathTM  clients benefit from several value-enhancing modules and features, including the
    following:

    •     Lean Process Improvement module tracks specimens from entry to storage, as well as day-to-day
    activities, and highlights potential areas of improvement in patient safety, staff productivity,
    quality control, and overall lab efficiency using powerful data analytics.
    •     Digital Pathology Readiness ensures that lab managers and pathologists have a seamless and
    elegant way to view and capture relevant information from digitized slides, improving turnaround
    time in the lab and allowing for remote diagnosis.

    •     Auto Case Distribution and Staff Scheduler dynamically distributes caseloads amongst
    pathologists during the workday while keeping track of workload, availability, and other variables.
     Staff Scheduler saves significant time for labs that manually assign caseload.
    •     NovoNotifier™ is a patient report delivery system that delivers patient reports to mobile
    devices and downloads and prints reports at a client’s site automatically upon release. This
    eliminates human intervention and delivers fast and reliable patient results.

    These modules and features integrate fully as part of a powerful LIS that includes functionalities
    expected in more expensive systems, such as personalized results for clients, electronic sign off
    and data exchange, a wide range of interfaces to other systems and instruments, voice dictation and
    recognition, and several methods of reporting results.

    "NovoPath™ is used to diagnose over 4 million new specimens each year and has a customer base of
    more than 309 sites. This software platform has experienced consistent growth due to its
    usefulness, broad functionality, and customizable features," said Supratik Paul, senior industry
    analyst. "Besides, it is cost effective, offers outstanding process optimization due to on-time
    delivery, and is simpler to use than competing solutions."

    NovoPath™ has found eager acceptance in customer segments ranging from specialized reference
    laboratories to large general hospitals. The company enjoys a huge competitive advantage in a
    market where clients desire customized LIS owing to constantly changing regulations and payment cap
    revisions. In addition to NovoPath’s success in the United States, the company has experienced
    growth in international markets as well.

    NovoPath™ has leveraged its brand to sign several strategic partnerships with leading healthcare
    and IT solutions providers, as well as software developers. For example, its partnership with
    Allscripts (formerly McKesson), a leading healthcare services and IT provider, has allowed
    Allscripts to present an integrated LIS solution to its customer base. Similarly, NovoPath worked
    with Philips IntelliSite Pathology Solution to develop an integrated digital imaging platform for
    viewing pathology slides, improving turn-around-time for labs, and offering actionable information.

    "Overall, Frost & Sullivan believes that NovoPath’s strategic partnerships with top healthcare
    service providers, modern technology, and solid brand equity in the AP ecosystem have positioned it
    as the AP LIS vendor of choice in the North American market," noted Supratik Paul .

    Each year, Frost & Sullivan presents this award to a company that has developed a pioneering
    technology that not only enhances current products, but also enables the development of new
    products and applications. The award recognizes the high market acceptance potential of the
    recipient’s technology.

    Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global
    markets for demonstrating outstanding achievement and superior performance in areas such as
    leadership, technological innovation, customer service, and strategic product development. Industry
    analysts compare market participants and measure performance through in-depth interviews, analysis,
    and extensive secondary research to identify best practices in the industry.

    About NovoPath

    NovoPath, Inc. is a leading U.S.-based Lab Information Systems (LIS) company with over 24 years of
    experience in serving the Anatomic, Clinical and Molecular Pathology, Genetic Testing and Clinical
    Trials marketplaces.  NovoPath's clients range from national and regional reference labs to
    University and

    Teaching Hospitals, Regional and Community Hospitals and Specialty Labs.  NovoPath's mission is to
    provide unique and unparalleled solutions and services to all aspects of the Diagnostic Laboratory
    sector in a way that improves workflow, reduces the probability of human error, ensures results
    accuracy for greater patient safety, protects patient confidentiality, and above all, produces more
    precise and informative diagnostic outcomes.

    About Frost & Sullivan

    Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage
    visionary innovation that addresses the global challenges and related growth opportunities that
    will make or break today's market participants. For more than 50 years, we have been developing
    growth strategies for the global 1000, emerging businesses, the public sector and the investment
    community. Contact us: Start the discussion.
    Contact:

    Samantha Park P: 210.247.2426
    F: 210.348.1003
    E: samantha.park@frost.com


 Additional Info

Included in the Export Interest Directory?
No
Business Needs:
Direct Sales